BackgroundSympathetic ophthalmia (SO) is a rare bilateral, diffuse granulomatous panuveitis that occurs following penetrating trauma or intraocular surgery to one eye, the exciting eye. The fellow non-traumatized sympathizing eye also shows similar inflammatory response usually with mutton-fat KPs suggesting involvement of autoimmune response [1]. Though the time from ocular injury to onset of SO was said to vary greatly, ranging from a few days to fifty years with 90% of the cases occurring within 1 year [2][3][4][5], recent series showed that only one-third of patients developed SO within 3 months and fewer than 50% did so within 1 year of injury [6].It has been speculated that an infectious agent or a bacterial antigen may precipitate an immune response resulting in the development of SO; but instigating organisms were not identified and the precise etiology of SO remains unknown to this time [5,7].The prevalence of SO is difficult to measure because it has always been a relatively rare disease plus as a result of improvements in modern surgical and medical treatments, it has now become even more uncommon. It accounted for about 0.3% of uveitis and its 1-year incidence was calculated to be a minimum of 0.03/100,000 population [8]. In a retrospective analysis of 2,340 cases of open-globe injuries in Iran, 0.08% (only two cases) was diagnosed with sympathetic ophthalmia from 1998 to 2003 [9].Patients with SO typically present with asymmetric bilateral panuveitis with more severe inflammation in the exciting eye than in the sympathizing eye at least initially. Signs and symptoms in the sympathizing eye vary in their severity and onset ranging from mild problem in near vision, photophobia and slight redness to very severe granulomatous anterior uveitis [5].Significant improvements in the management of ocular trauma combined with the advent of immune-modulators (including corticosteroids) and the use of antibiotics has led to a dramatic decrease in the incidence of sympathetic ophthalmia. However intraocular surgery is now considered the major risk factor particularly vitreoretinal surgery [10,11].
Case PresentationA 24-year-old male patient from Southwest Ethiopia presented to Jimma hospital eye department in March 2009 with pain and loss of right eye (OD) vision following trauma from a flying stone four months back. He was also having severe left eye (OS) pain associated with progressive reduction of vision, photophobia, redness and headache since three months. On examination, vision was no light perception (NLP) in OD and hand motion in OS. Intraocular pressure (IOP) was hypotonous in OD and 22mmHg in OS. The right eye was having hyperemic conjunctiva, irregular raised scleral scar nasally, hazy cornea, diffuse large KPs, shallow anterior chamber (A/C), irregular nonreactive pupil and contracted eyeball. In the left eye he was having ciliary flush, hazy cornea with endothelial dusting and many large KPs, A/C was deep, turbid aqueous with 4+ cells, sluggishly reactive pupil and limited lens and posterior segment...